London
· Delayed Price · Currency is GBP · Price in EUR Geratherm Medical AG Statistics
Total Valuation
Geratherm Medical AG has a market cap or net worth of GBP 16.83 million. The enterprise value is 17.20 million.
| Market Cap | 16.83M |
| Enterprise Value | 17.20M |
Important Dates
The next estimated earnings date is Wednesday, June 25, 2025.
| Earnings Date | Jun 25, 2025 |
| Ex-Dividend Date | Aug 19, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.89% |
| Shares Change (QoQ) | -11.89% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.66, with an EV/FCF ratio of -29.15.
| EV / Earnings | -24.43 |
| EV / Sales | 1.11 |
| EV / EBITDA | 12.66 |
| EV / EBIT | n/a |
| EV / FCF | -29.15 |
Financial Position
The company has a current ratio of 22.02, with a Debt / Equity ratio of 0.31.
| Current Ratio | 22.02 |
| Quick Ratio | 10.49 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 4.09 |
| Debt / FCF | -9.45 |
| Interest Coverage | -1.86 |
Financial Efficiency
Return on equity (ROE) is -4.53% and return on invested capital (ROIC) is -0.62%.
| Return on Equity (ROE) | -4.53% |
| Return on Assets (ROA) | -0.51% |
| Return on Capital (ROIC) | -0.62% |
| Revenue Per Employee | 86,709 |
| Profits Per Employee | -3,934 |
| Employee Count | 191 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 0.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.21% |
| 50-Day Moving Average | 5.68 |
| 200-Day Moving Average | 8.64 |
| Relative Strength Index (RSI) | 39.45 |
| Average Volume (20 Days) | 198 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Geratherm Medical AG had revenue of GBP 15.52 million and -704,112 in losses. Loss per share was -0.13.
| Revenue | 15.52M |
| Gross Profit | 11.36M |
| Operating Income | -248,295 |
| Pretax Income | -522,660 |
| Net Income | -704,112 |
| EBITDA | 1.36M |
| EBIT | -248,295 |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 5.37 million in cash and 5.57 million in debt, giving a net cash position of -205,605.
| Cash & Cash Equivalents | 5.37M |
| Total Debt | 5.57M |
| Net Cash | -205,605 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.12M |
| Book Value Per Share | 3.34 |
| Working Capital | 15.51M |
Cash Flow
In the last 12 months, operating cash flow was 27,978 and capital expenditures -618,060, giving a free cash flow of -590,082.
| Operating Cash Flow | 27,978 |
| Capital Expenditures | -618,060 |
| Free Cash Flow | -590,082 |
| FCF Per Share | n/a |
Margins
Gross margin is 73.16%, with operating and profit margins of -1.60% and -4.54%.
| Gross Margin | 73.16% |
| Operating Margin | -1.60% |
| Pretax Margin | -3.37% |
| Profit Margin | -4.54% |
| EBITDA Margin | 8.77% |
| EBIT Margin | -1.60% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 2.41%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 2.41% |
| Dividend Growth (YoY) | -33.90% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.89% |
| Shareholder Yield | 3.30% |
| Earnings Yield | -4.18% |
| FCF Yield | -3.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Geratherm Medical AG has an Altman Z-Score of 2.55. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.55 |
| Piotroski F-Score | n/a |